202 related articles for article (PubMed ID: 24136794)
1. "To share or not to share?" Serosorting by hepatitis C status in the sharing of drug injection equipment among NHBS-IDU2 participants.
Smith BD; Jewett A; Burt RD; Zibbell JE; Yartel AK; DiNenno E
J Infect Dis; 2013 Dec; 208(12):1934-42. PubMed ID: 24136794
[TBL] [Abstract][Full Text] [Related]
2. Serosorting for hepatitis C status in the sharing of injection equipment among Seattle area injection drug users.
Burt RD; Thiede H; Hagan H
Drug Alcohol Depend; 2009 Dec; 105(3):215-20. PubMed ID: 19720473
[TBL] [Abstract][Full Text] [Related]
3. Prevalence and risk factors associated with HIV/hepatitis B and HIV/hepatitis C co-infections among people who inject drugs in Mozambique.
Semá Baltazar C; Boothe M; Kellogg T; Ricardo P; Sathane I; Fazito E; Raymond HF; Temmerman M; Luchters S
BMC Public Health; 2020 Jun; 20(1):851. PubMed ID: 32493347
[TBL] [Abstract][Full Text] [Related]
4. Trends in sources and sharing of needles among people who inject drugs, San Francisco, 2005-2012.
Kim NJ; Jin H; McFarland W; Raymond HF
Int J Drug Policy; 2015 Dec; 26(12):1238-43. PubMed ID: 26365768
[TBL] [Abstract][Full Text] [Related]
5. Injection partnership characteristics and HCV status associations with syringe and equipment sharing among people who inject drugs.
Mackesy-Amiti ME; Boodram B; Page K; Latkin C
BMC Public Health; 2023 Jun; 23(1):1191. PubMed ID: 37340398
[TBL] [Abstract][Full Text] [Related]
6. High variability of HIV and HCV seroprevalence and risk behaviours among people who inject drugs: results from a cross-sectional study using respondent-driven sampling in eight German cities (2011-14).
Wenz B; Nielsen S; Gassowski M; Santos-Hövener C; Cai W; Ross RS; Bock CT; Ratsch BA; Kücherer C; Bannert N; Bremer V; Hamouda O; Marcus U; Zimmermann R;
BMC Public Health; 2016 Sep; 16(1):927. PubMed ID: 27595567
[TBL] [Abstract][Full Text] [Related]
7. Socio-behavioral and geographic correlates of prevalent hepatitis C virus infection among young injection drug users in metropolitan Baltimore and Chicago.
Boodram B; Golub ET; Ouellet LJ
Drug Alcohol Depend; 2010 Sep; 111(1-2):136-45. PubMed ID: 20472373
[TBL] [Abstract][Full Text] [Related]
8. Injecting risk behaviours following treatment for hepatitis C virus infection among people who inject drugs: The Australian Trial in Acute Hepatitis C.
Alavi M; Spelman T; Matthews GV; Haber PS; Day C; van Beek I; Walsh N; Yeung B; Bruneau J; Petoumenos K; Dolan K; Kaldor JM; Dore GJ; Hellard M; Grebely J;
Int J Drug Policy; 2015 Oct; 26(10):976-83. PubMed ID: 26115881
[TBL] [Abstract][Full Text] [Related]
9. Hepatitis C virus risk behaviors within the partnerships of young injecting drug users.
Hahn JA; Evans JL; Davidson PJ; Lum PJ; Page K
Addiction; 2010 Jul; 105(7):1254-64. PubMed ID: 20491725
[TBL] [Abstract][Full Text] [Related]
10. HIV infection and risk, prevention, and testing behaviors among injecting drug users -- National HIV Behavioral Surveillance System, 20 U.S. cities, 2009.
Broz D; Wejnert C; Pham HT; DiNenno E; Heffelfinger JD; Cribbin M; Krishna N; Teshale EH; Paz-Bailey G;
MMWR Surveill Summ; 2014 Jul; 63(6):1-51. PubMed ID: 24990587
[TBL] [Abstract][Full Text] [Related]
11. High regional variability of HIV, HCV and injecting risks among people who inject drugs in Poland: comparing a cross-sectional bio-behavioural study with case-based surveillance.
Rosińska M; Sierosławski J; Wiessing L
BMC Infect Dis; 2015 Feb; 15():83. PubMed ID: 25879904
[TBL] [Abstract][Full Text] [Related]
12. Epidemiology of HIV and hepatitis C infection among women who inject drugs in Northeast India: a respondent-driven sampling study.
McFall AM; Solomon SS; Lucas GM; Celentano DD; Srikrishnan AK; Kumar MS; Mehta SH
Addiction; 2017 Aug; 112(8):1480-1487. PubMed ID: 28317210
[TBL] [Abstract][Full Text] [Related]
13. Prevalence of HIV and other infections and injection behaviours among people who inject drugs in Addis Ababa, Ethiopia.
Demissie M; Johnston LG; Muleta M; Desyebelew D; Belete W; G/Egxiabehre A; Gezahegn N; Kassa D; Aseffa Y
Afr J AIDS Res; 2018 Sep; 17(3):259-264. PubMed ID: 30319040
[TBL] [Abstract][Full Text] [Related]
14. High prevalence of HIV, HBsAg and anti-HCV positivity among people who injected drugs: results of the first bio-behavioral survey using respondent-driven sampling in two urban areas in Mozambique.
Semá Baltazar C; Horth R; Boothe M; Sathane I; Young P; Chitsondzo Langa D; Condula M; Ricardo H; Dengo Baloi L; Cummings B; Schaad N; Gouveia L; Teodoro E; Raymond HF
BMC Infect Dis; 2019 Dec; 19(1):1022. PubMed ID: 31791273
[TBL] [Abstract][Full Text] [Related]
15. Development and validation of a novel scale for measuring interpersonal factors underlying injection drug using behaviours among injecting partnerships.
Morris MD; Neilands TB; Andrew E; Maher L; Page KA; Hahn JA
Int J Drug Policy; 2017 Oct; 48():54-62. PubMed ID: 28804051
[TBL] [Abstract][Full Text] [Related]
16. Injection-related hepatitis C serosorting behaviors among people who inject drugs: An urban/rural comparison.
Duncan I; Habecker P; Hautala D; Khan B; Dombrowski K
J Ethn Subst Abuse; 2019; 18(4):578-593. PubMed ID: 29436977
[TBL] [Abstract][Full Text] [Related]
17. Association of spatial proximity to fixed-site syringe services programs with HCV serostatus and injection equipment sharing practices among people who inject drugs in rural New England, United States.
Romo E; Stopka TJ; Jesdale BM; Wang B; Mazor KM; Friedmann PD
Harm Reduct J; 2024 Jan; 21(1):23. PubMed ID: 38282000
[TBL] [Abstract][Full Text] [Related]
18. Characteristics associated with HIV and hepatitis C seroprevalence among sexual and injecting partners of HIV positive persons who inject drugs in Nairobi and coastal Kenya.
Sambai BC; Kingston H; Monroe-Wise A; Mbogo L; Juma E; Ludwig-Barron N; Guthrie BL; Bukusi D; Chohan BH; Scott J; Bosire R; Dunbar M; Macharia P; Masyuko S; Sinkele W; Herbeck JT; Farquhar C
BMC Infect Dis; 2022 Jan; 22(1):73. PubMed ID: 35062890
[TBL] [Abstract][Full Text] [Related]
19. Age and gender-specific hepatitis C continuum of care and predictors of direct acting antiviral treatment among persons who inject drugs in Seattle, Washington.
Corcorran MA; Tsui JI; Scott JD; Dombrowski JC; Glick SN
Drug Alcohol Depend; 2021 Mar; 220():108525. PubMed ID: 33461152
[TBL] [Abstract][Full Text] [Related]
20. HIV and HCV discordant injecting partners and their association to drug equipment sharing.
De P; Cox J; Boivin JF; Platt RW; Jolly AM; Alexander PE
Scand J Infect Dis; 2009; 41(3):206-14. PubMed ID: 19172434
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
